Fact CheckerSign in

NCT07621575Completed

Active Drainage vs. Passive Drainage in MRM

Comparison Between Active Drainage And Passive Drainage In Post-Operative Seroma Formation After Modified Radical Mastectomy In Female Patients With Breast Carcinoma: A Prospective Randomized Controlled Trial.

Source: ClinicalTrials.gov · Last updated 2 Jun 2026

Brief summary (registry, in English)

The aim of the study is to compare between active drainage and passive drainage in post-operative seroma formation after modified radical mastectomy in female patient with breast carcinoma as regard of: Primary Outcomes: 1. Daily drain output (measured in mL/day). 2. Duration of the drain in place. 3. Amount of seroma aspiration after the drain removal. 4. Number of days till the last seroma aspiration. Secondary Outcomes: 1. Flap necrosis. 2. Surgical site infection. 100 female divided into two equal groups: * Group A: Active drainage group (50 patients). * Group B: Passive drainage group (50 patients). After MRM ,drain output was measured daily using a graduated jar by nurse during hospital stay which was a one to two days in an average and then by patient himself. All the data was recorded on a paper sheet. In passive drain, breast and axilla outcomes were combined together as one read to be equal to one active drain gar. Twice per week, I checked this reading by myself and reported any complications).

Status (registry)
Completed
Study type
Interventional
Enrollment
157 (actual)
First submitted
7 May 2026
Start date
30 May 2024
Primary completion date
10 May 2025
Lead sponsor
MOHAMED GAMAL AHMED ARAKEEB
NCT number
NCT07621575

What you commit to

  • Study type: Interventional
  • Participants enrolled: 157
  • From 30 May 2024 to the primary completion date, 10 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • • Previous breast surgery.
    • Active infection.
    • Recurrent or metastatic breast cancer (Stage IV).
    • Un-controlled diabetes mellitus (HbA1C \>7).
    • Coagulopathy disease.
    • Use of anticoagulant or antiplatelet medications.
    • Bilateral breast cancer.
    • Loss to follow-up within one month of drain removal.
    • Pregnancy.
    • Male breast cancer patients.

Who the study is looking for

  • Female patient diagnosed with breast carcinoma planned for MRM

Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kafrelsheikh University
Coordinator of this site? Confirm its status
Kafr ash ShaykhEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.